Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Acoustic Neuroma

imatinib mesylate has been researched along with Acoustic Neuroma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altuna, X; An, Y; Arandazi, MJ; Dobrow, R; Doherty, JK; Harris, JP; Lopez, JP; Ongkeko, WM; Wang-Rodriguez, J; Yu, MA1
Akgün, E; Avsar, T; Bayri, Y; Kılıç, T; Şeker, A; Yener, U1
DesJardins, A; Reardon, DA; Rich, JN; Sathornsumetee, S; Vredenburgh, JJ1

Other Studies

3 other study(ies) available for imatinib mesylate and Acoustic Neuroma

ArticleYear
Potential role of imatinib mesylate (Gleevec, STI-571) in the treatment of vestibular schwannoma.
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2011, Volume: 32, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Blotting, Western; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Imatinib Mesylate; Immunohistochemistry; Male; Middle Aged; Neuroma, Acoustic; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Tumor Cells, Cultured

2011
Assessment of antiangiogenic effect of imatinib mesylate on vestibular schwannoma tumors using in vivo corneal angiogenesis assay.
    Journal of neurosurgery, 2012, Volume: 117, Issue:4

    Topics: Animals; Antineoplastic Agents; Benzamides; Brain; Cornea; Cranial Nerve Neoplasms; Glioblastoma; Humans; Imatinib Mesylate; Male; Neovascularization, Pathologic; Neurofibromatosis 2; Neuroma, Acoustic; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Platelet-Derived Growth Factor; Treatment Outcome; Xenograft Model Antitumor Assays

2012
Neurofibromatosis type 2.
    Neurology, 2007, Mar-27, Volume: 68, Issue:13

    Topics: Antineoplastic Agents; Benzamides; Cochlear Nerve; Female; Functional Laterality; Hearing Loss, Sensorineural; Humans; Hydroxyurea; Imatinib Mesylate; Magnetic Resonance Imaging; Middle Aged; Neurofibromatosis 2; Neuroma, Acoustic; Piperazines; Pyrimidines; Treatment Outcome; Vestibular Nerve

2007